Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (13)
- (1,863)
- (104)
- (1)
- (1)
- (4)
- (50)
- (5)
- (8)
- (2)
- (15)
- (1)
- (3)
- (450)
- (8)
- (6)
- (1)
- (28,404)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (6)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (32,543)
- (196)
- (37)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (211)
- (2)
- (2)
- (1,308)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (52)
- (2)
- (2)
- (2)
- (1)
- (42)
- (12)
- (44)
- (31)
- (2)
- (54)
- (4)
- (186)
- (1)
- (172)
- (13)
- (12)
- (3)
- (6)
- (4)
- (120)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,513)
- (2)
- (1)
- (4)
Regulatory Status
- (85)
- (97,220)
For Use With (Application)
- (2)
- (1)
- (3,448)
- (1)
- (28,534)
- (1)
- (65)
- (548)
- (9,418)
- (24)
- (1)
- (8)
- (2)
- (8)
- (3)
- (2)
- (2)
- (1)
- (2)
- (227)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (1)
- (5)
- (1)
- (1)
- (248)
- (3)
- (27,118)
- (1)
- (1)
- (1)
- (32)
- (3)
- (1)
- (49,467)
- (1,378)
- (2)
- (4)
- (3)
- (37)
- (791)
- (4)
- (3)
- (2)
- (1)
- (125)
- (1)
- (323)
- (2,825)
- (3)
- (65)
- (7)
- (566)
- (4)
- (19,645)
- (23)
- (2)
- (32)
- (19)
- (181)
- (21)
- (3)
- (120)
- (151)
- (99)
- (2)
- (2)
- (15)
- (3)
- (1)
- (1,606)
- (2)
- (4)
- (1)
- (35)
- (690)
- (2)
- (1)
- (2)
- (2)
- (9)
- (11)
- (2)
- (21,927)
- (4,209)
- (3)
- (4)
- (6)
- (1)
- (1)
- (1)
- (3)
- (3)
- (1)
- (1)
- (47,864)
- (5)
- (2)
- (1)
- (62)
- (4)
- (5)
- (3)
- (1)
- (6)
- (1)
- (1)
- (10,886)
- (4)
- (53)
- (1)
- (5)
- (13)
- (2)
- (4)
- (12)
- (5)
- (6)
- (1)
- (49,851)
- (1,912)
Recombinant
- (17)
- (70,607)
- (19)
Form
- (3)
- (4)
- (51,672)
- (8,199)
- (3,526)
- (144)
- (17)
- (3,404)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
82,847
results
1
Promotions Available
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
![]()
Gibco™ Human/Mouse/Rat BDNF Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | BDNF |
| Molecular Weight (g/mol) | 27 kDa |
| Gene Symbol | BDNF |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
| Expression System | E. coli |
| For Use With (Application) | Binding Assay,Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human/Mouse/Rat BDNF |
| Accession Number | P21237, P23363, P23560 |
| Gene Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
| Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
| Gene ID (Entrez) | 12064, 24225, 627 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
2
Promotions Available
Gibco™ Human FGF-basic (FGF-2/bFGF) (154 aa) Recombinant Protein, PeproTech®
![]()
Gibco™ Human FGF-basic (FGF-2/bFGF) (154 aa) Recombinant Protein, PeproTech®
Recombinant Protein
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17.2 kDa |
| Gene Symbol | FGF2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
| Accession Number | P09038 |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 2247 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
3
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GDNF |
| Molecular Weight (g/mol) | 30.4 kDa |
| Gene Symbol | GDNF |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MSPDKQMAVL PRRERNRQAA AANPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELIFRYCS GSCDAAETTY DKILKNLSRN RRLVSDKVGQ ACCRPIAFDD DLSFLDDNLV YHILRKHSAK RCGCI |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,Western Blot Control |
| Source | E. coli |
| Name | Human GDNF |
| Accession Number | P39905 |
| Gene Alias | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
| Biological Activity | Determined by a cell proliferation assay using SH-SY5Y cells. The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 2668 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
4
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 26.7 kDa |
| Common Name | RSPO1 |
| Gene Symbol | RSPO1 |
| Activity | R-Spondin-1 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 is 1.0-3.0 ug/ml. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKQQLCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKGQQQQQQ QGTVGPLTSA GPA |
| Expression System | CHO cells |
| For Use With (Application) | Bioactivity,Control |
| Name | Human R-Spondin 1 |
| Accession Number | Q2MKA7 |
| Purification Method | Purified |
| Gene Alias | CRISTIN3; cristin-3; cysteine-rich and single thrombospondin domain-containing protein 3; FLJ40906; hRspo1; mCristin-3; RGD1565558; Roof plate-specific spondin-1; RP11-566C13.1; RSPO; RSPO1; Rspondin; R-spondin; R-spondin 1; R-spondin homolog; R-spondin homolog (Xenopus laevis); R-spondin-1; thrombospondin type 1 domain containing gene Rspondin |
| Product Type | Protein |
| Gene ID (Entrez) | 284654 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
5
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IFN gamma |
| Molecular Weight (g/mol) | 16.8 kDa |
| Gene Symbol | IFNG |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human IFN-gamma |
| Accession Number | P01579 |
| Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN γ; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFNγ; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon γ; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferonγ; M-IFN-g; R-IFN-g |
| Biological Activity | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
| Gene ID (Entrez) | 3458 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
6
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-13 |
| Molecular Weight (g/mol) | 12.6 kDa |
| Gene Symbol | Il13 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MSPGPVPPST ALRELIEELV NITQNQKAPL CNGSMVWSIN LTAGMYCAAL ESLINVSGCS AIEKTQRMLS GFCPHKVSAG QFSSLHVRDT KIEVAQFVKD LLLHLKKLFR EGRFN |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,Western Blot Control |
| Source | E. coli |
| Name | Human IL-13 |
| Accession Number | P35225 |
| Gene Alias | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
| Biological Activity | The ED50 as determined by the dose-dependent proliferation of TF-1 cells was ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 3596 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
8
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Gene Symbol | EGF |
| Endotoxin Concentration | <0.1 EU/μg |
| Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human EGF, Animal-Free |
| Accession Number | P01133 |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 1950 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
9
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | EGF |
| Molecular Weight (g/mol) | 6.2 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human EGF |
| Purification Method | Purified |
| Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Stem Cell Research, Oncology |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Wet Ice |
| Content And Storage | 4°C |
| Gene Symbol | EGF |
| Storage Requirements | 4°C |
| Protein Subtype | EGF (Epidermal Growth Factor) |
| Accession Number | P01133 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 1950 |
| Product Line | Gibco |
10
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-10 |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | IL10 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MSPGQGTQSE NSCTHFPGNL PNMLRDLRDA FSRVKTFFQM KDQLDNLLLK ESLLEDFKGY LGCQALSEMI QFYLEEVMPQ AENQDPDIKA HVNSLGENLK TLRLRLRRCH RFLPCENKSK AVEQVKNAFN KLQEKGIYKA MSEFDIFINY IEAYMTMKIR N |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human IL-10 |
| Accession Number | P22301 |
| Gene Alias | CSIF; cytokine; Cytokine synthesis inhibitory factor; GVHDS; H-IL-10; il 10; IL10; IL-10; IL-10 precursor; IL10A; IL10X; ILN; Interleukin; interleukin 10; Interleukin10; interleukin-10; MGC126450; MGC126451; RP11-262N9.1; T-cell growth inhibitory factor; TGIF |
| Biological Activity | Determined by the dose-dependent co-stimulation (with human IL-4) of MC/9 cells. The ED50 was found to be ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 3586 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
11
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 46 kDa |
| Common Name | Noggin |
| Gene Symbol | NOG |
| Activity | Determined by its ability to inhibit 5.0 ng/ml of BMP-4 induced alkaline phosphatase production by ATDC-5 chondrogenic cells. The expected ED50 for this effect is 2.0-3.0 ng/ml of Noggin. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | QHYLHIRPAP SDNLPLVDLI EHPDPIFDPK EKDLNETLLR SLLGGHYDPG FMATSPPEDR PGGGGGAAGG AEDLAELDQL LRQRPSGAMP SEIKGLEFSE GLAQGKKQRL SKKLRRKLQM WLWSQTFCPV LYAWNDLGSR FWPRYVKVGS CFSKRSCSVP EGMVCKPSKS VHLTVLRWRC QRRGGQRCGW IPIQYPIISE CKCSC |
| Expression System | HEK293 cells |
| For Use With (Application) | Bioactivity,Control |
| Name | Human Noggin |
| Accession Number | Q13253 |
| Purification Method | Purified |
| Gene Alias | NOG; Noggin; Noggin precursor; noggin; LOW QUALITY PROTEIN: noggin; SYM1; symphalangism 1 (proximal); SYNS1; SYNS1A |
| Product Type | Protein |
| Gene ID (Entrez) | 9241 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
12
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-6 |
| Molecular Weight (g/mol) | 20.9 kDa |
| Gene Symbol | Il6 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | PVPPGEDSKD VAAPHRQPLT SSERIDKQIR YILDGISALR KETCNKSNMC ESSKEALAEN NLNLPKMAEK DGCFQSGFNE ETCLVKIITG LLEFEVYLEY LQNRFESSEE QARAVQMSTK VLIQFLQKKA KNLDAITTPD PTTNASLLTK LQAQNQWLQD MTTHLILRSF KEFLQSSLRA LRQM |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human IL-6 |
| Accession Number | P05231 |
| Gene Alias | B-cell differentiation factor; B-cell hybridoma growth factor; B-cell stimulatory factor 2; BSF2; BSF-2; CDF; CHIL-6; CTL differentiation factor; cytokine; HGF; H-IL-6; HSF; hybridoma growth factor; Ifnb2; IFN-beta-2; Il6; IL-6; ILg6; ILN; interferon beta-2; Interleukin; interleukin 6; Interleukin 6 (interferon, beta 2); interleukin 6 precursor; interleukin BSF-2; interleukin HP-1; Interleukin6; Interleukin-6; interleukin-6 precursor; interleukin-6 protein; M-IL-6; prointerleukin 6; R-IL-6 |
| Biological Activity | Determined by its ability to stimulate the proliferation of mouse B9 cells. |
| Gene ID (Entrez) | 3569 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
13
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 17.5 kDa |
| Common Name | IL-7 |
| Gene Symbol | Il7, IL7r |
| Activity | The ED50 was determined by the dose-dependent stimulation of the proliferation of murine 2E8 cells is ≤ 0.5 ng/ml, corresponding to a specific activity of ≥ 2 x 10^6 units/mg. |
| Endotoxin Concentration | <1 EU/μg |
| Storage Requirements | -20°C |
| Sequence | MDCDIEGKDG KQYESVLMVS IDQLLDSMKE IGSNCLNNEF NFFKRHICDA NKEGMFLFRA ARKLRQFLKM NSTGDFDLHL LKVSEGTTIL LNCTGQVKGR KPAALGEAQP TKSLEENKSL KEQKKLNDLC FLKRLLQEIK TCWNKILMGT KEH |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Name | Human IL-7 |
| Accession Number | P13232, P16871 |
| Purification Method | Purified |
| Gene Alias | A630026I06Rik; H-IL-7; hlb368; IL7; Il-7; ILN; Interleukin; interleukin 7; Interleukin7; interleukin-7; M-IL-7 |
| Product Type | Protein |
| Gene ID (Entrez) | 3574, 3575 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
14
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | VEGF-165 |
| Molecular Weight (g/mol) | 38.2 kDa |
| Gene Symbol | Vegfa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | APMAEGGGQN HHEVVKFMDV YQRSYCHPIE TLVDIFQEYP DEIEYIFKPS CVPLMRCGGC CNDEGLECVP TEESNITMQI MRIKPHQGQH IGEMSFLQHN KCECRPKKDR ARQENPCGPC SERRKHLFVQ DPQTCKCSCK NTDSRCKARQ LELNERTCRC DKPRR |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human VEGF-165 |
| Accession Number | P15692 |
| Gene Alias | H-VEGF-165; MVCD1; M-VEGF-165; vascular endothelial growth factor 165b; vascular endothelial growth factor A; vascular endothelial growth factor A121; vascular endothelial growth factor A165; vascular permeability factor; VEGF; VEGF164; VEGF165; Vegfa; VEGF-A; VPF |
| Biological Activity | Determined by its ability to stimulate the proliferation of human umbilical vein endothelial cells (HUVEC). The expected ED50 for this effect is 1.0-10.0 ng/ml |
| Gene ID (Entrez) | 7422 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
15
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IL-2 |
| Molecular Weight (g/mol) | 15.5 kDa |
| Gene Symbol | IL2 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFAQSII STLT |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity,Control,ELISA Standard,Western Blot Control |
| Source | E. coli |
| Name | Human IL-2 |
| Accession Number | P60568 |
| Gene Alias | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of murine CTLL-2 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Gene ID (Entrez) | 3558 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |